[HTML][HTML] Pharmaceutical targeting the envelope protein of SARS-CoV-2: the screening for inhibitors in approved drugs

A Chernyshev - 2020 - europepmc.org
An essential overview of the biological role of coronavirus viroporin (envelope protein) is
given, together with the effect of its known inhibitors on the life cycle of coronavirus. A …

Characterization of the SARS‐CoV‐2 E protein: sequence, structure, viroporin, and inhibitors

Y Cao, R Yang, I Lee, W Zhang, J Sun, W Wang… - Protein …, 2021 - Wiley Online Library
The COVID‐19 epidemic is one of the most influential epidemics in history. Understanding
the impact of coronaviruses (CoVs) on host cells is very important for disease treatment. The …

Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2

U Breitinger, NS Farag, H Sticht… - The international journal of …, 2022 - Elsevier
Viroporins are indispensable for viral replication. As intracellular ion channels they disturb
pH gradients of organelles and allow Ca 2+ flux across ER membranes. Viroporins interact …

Comparative analysis of SARS-CoV-2 envelope viroporin mutations from COVID-19 deceased and surviving patients revealed implications on its ion-channel …

T Rizwan, A Kothidar, H Meghwani… - Journal of …, 2022 - Taylor & Francis
One major obstacle in designing a successful therapeutic regimen to combat COVID-19
pandemic is the frequent occurrence of mutations in the SARS-CoV-2 resulting in patient to …

Structure and dynamics of the SARS‐CoV‐2 envelope protein monomer

A Kuzmin, P Orekhov, R Astashkin… - Proteins: Structure …, 2022 - Wiley Online Library
Coronaviruses, especially severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),
present an ongoing threat to human wellbeing. Consequently, elucidation of molecular …

[HTML][HTML] Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2

U Breitinger, CA Sedky, H Sticht, HG Breitinger - Virology Journal, 2023 - Springer
Background SARS-CoV-2 has caused a worldwide pandemic since December 2019 and the
search for pharmaceutical targets against COVID-19 remains an important challenge. Here …

In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor

D Dey, S Borkotoky, M Banerjee - Computers in biology and medicine, 2020 - Elsevier
Viroporins are oligomeric, pore forming, viral proteins that play critical roles in the life cycle
of pathogenic viruses. Viroporins like HIV-1 Vpu, Alphavirus 6 K, Influenza M2, HCV p7, and …

[HTML][HTML] An overview of the crystallized structures of the SARS-CoV-2

MI Ionescu - The protein journal, 2020 - Springer
Many research teams all over the world focus their research on the SARS-CoV-2, the new
coronavirus that causes the so-called COVID-19 disease. Most of the studies identify the …

[HTML][HTML] Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits

GG Rossetti, MA Ossorio, S Rempel, A Kratzel… - Scientific reports, 2022 - nature.com
Mpro, the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), is essential for the viral life cycle. Accordingly, several groups have performed in …

Potential unconventional medicines for the treatment of SARS-CoV-2

M Coppola, R Mondola - Drug research, 2020 - thieme-connect.com
SARS-CoV-2 infection was first isolated in Wuhan in the end of December 2019, since then,
this β-coronavirus has rapidly spread becoming the most important public health concern …